ACLX
Price
$75.63
Change
+$0.42 (+0.56%)
Updated
Dec 20, 04:59 PM (EDT)
88 days until earnings call
RCKT
Price
$11.56
Change
+$0.21 (+1.85%)
Updated
Dec 20 closing price
74 days until earnings call
Ad is loading...

ACLX vs RCKT

Header iconACLX vs RCKT Comparison
Open Charts ACLX vs RCKTBanner chart's image
Arcellx
Price$75.63
Change+$0.42 (+0.56%)
Volume$4.84K
CapitalizationN/A
Rocket Pharmaceuticals
Price$11.56
Change+$0.21 (+1.85%)
Volume$2.87M
CapitalizationN/A
ACLX vs RCKT Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. RCKT commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and RCKT is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ACLX: $75.54 vs. RCKT: $11.56)
Brand notoriety: ACLX and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 223% vs. RCKT: 265%
Market capitalization -- ACLX: $4.09B vs. RCKT: $1.23B
ACLX [@Biotechnology] is valued at $4.09B. RCKT’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 6 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -9.86% price change this week, while RCKT (@Biotechnology) price change was -3.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.09B) has a higher market cap than RCKT($1.23B). ACLX YTD gains are higher at: 36.108 vs. RCKT (-61.428). ACLX has higher annual earnings (EBITDA): -33.12M vs. RCKT (-247.25M). ACLX has more cash in the bank: 574M vs. RCKT (236M). RCKT has less debt than ACLX: RCKT (25.6M) vs ACLX (65.3M). ACLX has higher revenues than RCKT: ACLX (156M) vs RCKT (0).
ACLXRCKTACLX / RCKT
Capitalization4.09B1.23B332%
EBITDA-33.12M-247.25M13%
Gain YTD36.108-61.428-59%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash574M236M243%
Total Debt65.3M25.6M255%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXRCKT
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRKQX7.380.10
+1.37%
PGIM Real Estate Income R6
SECEX25.540.26
+1.03%
NAA Large Core A
LSSNX30.970.19
+0.62%
Loomis Sayles Small Cap Growth N
CVSCX15.32N/A
N/A
Calamos Market Neutral Income C
SMFCX26.88-1.10
-3.93%
American Beacon Stephens Mid-Cap Gr C

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.44%
DNLI - ACLX
49%
Loosely correlated
-0.19%
BEAM - ACLX
49%
Loosely correlated
+8.04%
RCKT - ACLX
48%
Loosely correlated
+1.85%
CRSP - ACLX
47%
Loosely correlated
+0.83%
RCUS - ACLX
47%
Loosely correlated
+0.26%
More